|
US6822267B1
(en)
*
|
1997-08-20 |
2004-11-23 |
Advantest Corporation |
Signal transmission circuit, CMOS semiconductor device, and circuit board
|
|
EP1169031A1
(en)
*
|
1999-04-09 |
2002-01-09 |
British Biotech Pharmaceuticals Limited |
Antimicrobial agents
|
|
EA200601252A1
(ru)
*
|
1999-09-08 |
2006-10-27 |
Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч |
Новый класс веществ, вызывающих дифференцировку клеток и являющихся ингибиторами гистондеацетилазы, и способы их применения
|
|
KR20020070285A
(ko)
*
|
1999-11-23 |
2002-09-05 |
메틸진, 인크. |
히스톤 디아세틸라제의 억제제
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
CA2423744C
(en)
|
2000-09-29 |
2012-04-03 |
Prolifix Limited |
Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
|
|
EP1335898B1
(en)
|
2000-09-29 |
2005-11-23 |
TopoTarget UK Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
|
US8026280B2
(en)
*
|
2001-03-27 |
2011-09-27 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
US7842727B2
(en)
*
|
2001-03-27 |
2010-11-30 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
US7312247B2
(en)
|
2001-03-27 |
2007-12-25 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
EP1409661A4
(en)
|
2001-06-14 |
2006-02-01 |
Sloan Kettering Inst Cancer |
HDAC9 POLYPEPTIDES, POLYNUCLEOTIDES AND USES THEREOF
|
|
HU229521B1
(hu)
|
2001-08-21 |
2014-01-28 |
Astellas Pharma Inc |
A hiszton-dezacetiláz inhibitor gyógyászati alkalmazása, és eljárás tumorellenes hatásának kiértékelésére
|
|
EP1443928B1
(en)
|
2001-10-16 |
2011-07-27 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases and cancer of the brain
|
|
WO2003033678A2
(en)
|
2001-10-18 |
2003-04-24 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
|
|
US20050288227A1
(en)
*
|
2002-02-15 |
2005-12-29 |
Marks Paul A |
Use of thioredoxin measurements for diagnostics and treatments
|
|
JP2005525345A
(ja)
*
|
2002-02-15 |
2005-08-25 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
Ｔｒｘ媒介性疾患を処置する方法
|
|
US20040132825A1
(en)
*
|
2002-03-04 |
2004-07-08 |
Bacopoulos Nicholas G. |
Methods of treating cancer with HDAC inhibitors
|
|
US7148257B2
(en)
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
|
US7456219B2
(en)
|
2002-03-04 |
2008-11-25 |
Merck Hdac Research, Llc |
Polymorphs of suberoylanilide hydroxamic acid
|
|
US20070060614A1
(en)
*
|
2002-03-04 |
2007-03-15 |
Bacopoulos Nicholas G |
Methods of treating cancer with hdac inhibitors
|
|
US20060276547A1
(en)
*
|
2002-03-04 |
2006-12-07 |
Bacopoulos Nicholas G |
Methods of treating cancer with HDAC inhibitors
|
|
WO2003075839A2
(en)
*
|
2002-03-04 |
2003-09-18 |
Aton Pharma, Inc. |
Methods of inducing terminal differentiation
|
|
ATE458047T1
(de)
|
2002-03-07 |
2010-03-15 |
Univ Delaware |
Verfahren zur verstärkung der oligonucleotid- vermittelten nucleinsäuresequenzänderung unter verwendung von zusammensetzungen mit einem hydroxyharnstoff
|
|
CN100566711C
(zh)
*
|
2002-04-15 |
2009-12-09 |
斯隆-凯特林癌症研究院 |
治疗癌症的化合物及其用途
|
|
WO2003099272A1
(en)
*
|
2002-05-22 |
2003-12-04 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
|
|
TW559390U
(en)
*
|
2002-08-27 |
2003-10-21 |
Molex Inc |
Electrical connector
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7250514B1
(en)
|
2002-10-21 |
2007-07-31 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
JP2006512318A
(ja)
*
|
2002-11-12 |
2006-04-13 |
アルコン，インコーポレイテッド |
眼の血管新生もしくは水腫状の疾患および障害を処置するためのヒストンデアセチラーゼインヒビター
|
|
WO2004046104A2
(en)
|
2002-11-20 |
2004-06-03 |
Errant Gene Therapeutics, Llc |
Treatment of lung cells with histone deacetylase inhibitors
|
|
US7244751B2
(en)
|
2003-02-14 |
2007-07-17 |
Shenzhen Chipscreen Biosciences Ltd. |
Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
|
|
CA2518318A1
(en)
|
2003-03-17 |
2004-09-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
CN1839121A
(zh)
*
|
2003-04-01 |
2006-09-27 |
斯隆-凯特林癌症研究所 |
异羟肟酸化合物及其使用方法
|
|
CN1791396A
(zh)
*
|
2003-05-21 |
2006-06-21 |
诺瓦提斯公司 |
组蛋白脱乙酰基酶抑制剂与化疗剂的组合
|
|
EP1644323B1
(en)
*
|
2003-07-07 |
2015-03-18 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
US7842835B2
(en)
*
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
KR100924737B1
(ko)
|
2003-08-26 |
2009-11-04 |
슬로안-케테링인스티튜트퍼캔서리서치 |
Ｈｄａｃ 억제제를 이용한 암의 치료 방법
|
|
CA2535889A1
(en)
*
|
2003-08-29 |
2005-03-17 |
Aton Pharma, Inc. |
Combination methods of treating cancer
|
|
WO2005034880A2
(en)
*
|
2003-10-09 |
2005-04-21 |
Aton Pharma, Inc. |
Thiophene and benzothiophene hydroxamic acid derivatives
|
|
CN1905881A
(zh)
*
|
2003-11-26 |
2007-01-31 |
阿托恩药品公司 |
二胺和亚氨二醋酸异羟肟酸衍生物
|
|
WO2005053609A2
(en)
*
|
2003-11-26 |
2005-06-16 |
Guilford Pharmaceuticals Inc. |
Methods of nad+-dependent deacetylase inhibitors
|
|
US20080004290A1
(en)
*
|
2003-11-28 |
2008-01-03 |
The University Of Queensland |
Anti-Cancer Agents
|
|
EP1697538A1
(en)
*
|
2003-12-18 |
2006-09-06 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Method for identifying histone deacetylase inhibitors
|
|
US20050137234A1
(en)
*
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
WO2005065681A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
|
|
US20080113874A1
(en)
*
|
2004-01-23 |
2008-05-15 |
The Regents Of The University Of Colorado |
Gefitinib sensitivity-related gene expression and products and methods related thereto
|
|
US8017321B2
(en)
*
|
2004-01-23 |
2011-09-13 |
The Regents Of The University Of Colorado, A Body Corporate |
Gefitinib sensitivity-related gene expression and products and methods related thereto
|
|
WO2005097747A1
(en)
*
|
2004-04-05 |
2005-10-20 |
Aton Pharma, Inc. |
Histone deacetylase inhibitor prodrugs
|
|
WO2005117553A2
(en)
|
2004-05-27 |
2005-12-15 |
The Regents Of The University Of Colorado |
Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
|
|
WO2006005941A1
(en)
*
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti S.P.A. |
Amide derivatives as inhibitors of histone deacetylase
|
|
JP2008505970A
(ja)
*
|
2004-07-12 |
2008-02-28 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤
|
|
WO2006017216A1
(en)
*
|
2004-07-12 |
2006-02-16 |
Merck & Co., Inc. |
Histone deacetylase inhibitors
|
|
WO2006005955A1
(en)
*
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Amide derivatives as inhibitors of histone deacetylase
|
|
JP2008506776A
(ja)
*
|
2004-07-19 |
2008-03-06 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤
|
|
KR20070057822A
(ko)
*
|
2004-08-09 |
2007-06-07 |
아스텔라스세이야쿠 가부시키가이샤 |
히스톤 디아세틸라제 (ｈｄａｃ) 억제제 활성을 갖는히드록시아미드 화합물
|
|
CN101035542A
(zh)
*
|
2004-08-25 |
2007-09-12 |
默克公司 |
组蛋白脱乙酰基酶抑制剂
|
|
KR100584811B1
(ko)
|
2004-10-21 |
2006-05-30 |
한국화학연구원 |
히스톤 디아세틸라제 저해활성을 갖는ｎ,ｎ-다이메틸아미노페닐 옥타노산 하이드록시아마이드유도체 및 이의 제조방법
|
|
US7235688B1
(en)
|
2004-11-04 |
2007-06-26 |
University Of Notre Dame Du Lac |
Process for preparing histone deacetylase inhibitors and intermediates thereof
|
|
US20070021612A1
(en)
*
|
2004-11-04 |
2007-01-25 |
University Of Notre Dame Du Lac |
Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof
|
|
CA2587013A1
(en)
*
|
2004-11-08 |
2006-05-18 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
JP2008524246A
(ja)
|
2004-12-16 |
2008-07-10 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
WO2006094068A2
(en)
|
2005-03-01 |
2006-09-08 |
The Regents Of The University Of Michigan |
Hdac inhibitors that promote brm expression and brm related diagnostics
|
|
US20080234265A1
(en)
*
|
2005-03-11 |
2008-09-25 |
The Regents Of The University Of Colorado |
Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors
|
|
WO2006113606A2
(en)
*
|
2005-04-18 |
2006-10-26 |
Johns Hopkins University |
Histone deacetylase inhibitors
|
|
CA2605110A1
(en)
*
|
2005-04-20 |
2006-11-02 |
Merck & Co., Inc. |
Benzothiophene derivatives
|
|
AU2006240248A1
(en)
*
|
2005-04-20 |
2006-11-02 |
Merck Sharp & Dohme Corp. |
Benzothiophene hydroxamic acid derivatives
|
|
AU2006240246A1
(en)
|
2005-04-20 |
2006-11-02 |
Merck Sharp & Dohme Corp. |
Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions
|
|
GB0509226D0
(en)
*
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme and receptor modulation
|
|
BRPI0610368A8
(pt)
*
|
2005-05-05 |
2015-09-08 |
Glaxosmithkline Ip Dev Ltd |
Modulação de enzima e de receptor
|
|
GB0509225D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of enzymatic activity
|
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
US7642253B2
(en)
*
|
2005-05-11 |
2010-01-05 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
TWI365068B
(en)
|
2005-05-20 |
2012-06-01 |
Merck Sharp & Dohme |
Formulations of suberoylanilide hydroxamic acid and methods for producing same
|
|
JP2008546793A
(ja)
*
|
2005-06-24 |
2008-12-25 |
メルク エンド カムパニー インコーポレーテッド |
修飾マロン酸誘導体
|
|
EA200800321A1
(ru)
|
2005-07-14 |
2008-06-30 |
Такеда Сан Диего, Инк. |
Ингибиторы гистондеацетилазы
|
|
GB0518237D0
(en)
*
|
2005-09-07 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
KR100696139B1
(ko)
*
|
2005-11-01 |
2007-03-20 |
한국화학연구원 |
히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시 옥테노일 하이드록시아마이드 유도체 및그의 제조방법
|
|
WO2007055942A2
(en)
*
|
2005-11-03 |
2007-05-18 |
Merck & Co., Inc. |
Substituted nicotinamide compounds
|
|
CA2626897A1
(en)
|
2005-11-03 |
2007-05-18 |
Joshua Close |
Histone deacetylase inhibitors with aryl-pyrazolyl motifs
|
|
JP2009514891A
(ja)
*
|
2005-11-04 |
2009-04-09 |
メルク エンド カムパニー インコーポレーテッド |
癌を治療するためのｓａｈａ及びエルロチニブを用いる方法
|
|
CA2636596A1
(en)
*
|
2005-11-04 |
2007-05-18 |
James Pluda |
Method of treating cancers with saha and pemetrexed
|
|
JP2009515887A
(ja)
|
2005-11-11 |
2009-04-16 |
ザ スクリプス リサーチ インスティテュート |
神経系疾患のための治療薬としてのヒストンデアセチラーゼ阻害剤
|
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
|
PT1975158E
(pt)
*
|
2005-12-27 |
2011-09-23 |
Ct Nac Investigaciones Oncologicas Cnio |
Novos derivados de pirrole com actividade inibidora de histona desacetilase
|
|
EP1973405A4
(en)
*
|
2006-01-12 |
2011-06-01 |
Merck Sharp & Dohme |
HYDROXYALKYLARYLAMID DERIVATIVES
|
|
CA2635209A1
(en)
*
|
2006-01-12 |
2007-08-02 |
Merck & Co., Inc. |
Fluorinated arylamide derivatives
|
|
WO2007084390A2
(en)
*
|
2006-01-13 |
2007-07-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
KR20080091297A
(ko)
*
|
2006-02-07 |
2008-10-09 |
아스텔라스세이야쿠 가부시키가이샤 |
Ｎ-히드록시아크릴아미드 화합물
|
|
AU2007214458C1
(en)
|
2006-02-14 |
2012-12-06 |
Dana-Farber Cancer Institute, Inc. |
Histone deacetylase inhibitors
|
|
GB0603041D0
(en)
*
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
JP2009528354A
(ja)
*
|
2006-02-28 |
2009-08-06 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素のインヒビター
|
|
WO2007113644A2
(en)
*
|
2006-04-05 |
2007-10-11 |
Orchid Research Laboratories Limited |
New hdac inhibitors
|
|
WO2007145704A2
(en)
|
2006-04-24 |
2007-12-21 |
Gloucester Pharmaceuticals |
Gemcitabine combination therapy
|
|
CA2649861A1
(en)
*
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
CA2651681A1
(en)
*
|
2006-05-18 |
2007-11-29 |
Merck & Co., Inc. |
Aryl-fused spirocyclic compounds
|
|
US8957027B2
(en)
|
2006-06-08 |
2015-02-17 |
Celgene Corporation |
Deacetylase inhibitor therapy
|
|
EP2049124A4
(en)
*
|
2006-07-20 |
2010-02-10 |
Merck & Co Inc |
PHOSPHOR DERIVATIVES AS HISTONDEACETYLASE HEMMER
|
|
EP2056808A4
(en)
*
|
2006-08-28 |
2009-12-23 |
Univ California |
Small molecule potentiator of hormonal therapy for breast cancer
|
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
|
WO2008039421A2
(en)
|
2006-09-28 |
2008-04-03 |
Merck & Co., Inc. |
Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes
|
|
GB0619753D0
(en)
|
2006-10-06 |
2006-11-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
GB0620823D0
(en)
*
|
2006-10-19 |
2006-11-29 |
Univ London |
Histone deacetylase inhibitors
|
|
US8962825B2
(en)
|
2006-10-30 |
2015-02-24 |
Glaxosmithkline Intellectual Property Development Limited |
Hydroxamates as inhibitors of histone deacetylase
|
|
CN101528037A
(zh)
*
|
2006-11-03 |
2009-09-09 |
默克公司 |
使用saha和硼替佐米治疗多发性骨髓瘤的方法
|
|
WO2008083288A2
(en)
|
2006-12-29 |
2008-07-10 |
Gloucester Pharmaceuticals |
Purifiction of romidepsin
|
|
BRPI0806365B8
(pt)
|
2007-02-06 |
2021-05-25 |
Lixte Biotechnology Holdings Inc |
composto, uso do composto, composição farmacêutica e uso da composição farmacêutica
|
|
US20100324034A1
(en)
*
|
2007-02-08 |
2010-12-23 |
Hazuda Daria J |
Methods of Using SAHA for Treating HIV Infection
|
|
GB2445630B
(en)
*
|
2007-03-12 |
2008-11-12 |
Cvon Innovations Ltd |
Dynamic message allocation system and method
|
|
AU2008225833A1
(en)
*
|
2007-03-13 |
2008-09-18 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Amide compounds and their use as antitumor agents
|
|
US20080288310A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Cvon Innovation Services Oy |
Methodologies and systems for mobile marketing and advertising
|
|
EP2167090A4
(en)
|
2007-06-06 |
2010-08-25 |
Univ Maryland |
HDAC INHIBITORS AND HORMONE TREATMENT MEDICAMENTS
|
|
EP3103791B1
(en)
|
2007-06-27 |
2018-01-31 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
WO2009005638A2
(en)
*
|
2007-06-27 |
2009-01-08 |
Merck & Co., Inc. |
Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
|
|
JP5730575B2
(ja)
|
2007-10-01 |
2015-06-10 |
リクスト・バイオテクノロジー，インコーポレイテッド |
Ｈｄａｃ阻害剤
|
|
US20110053991A1
(en)
*
|
2007-11-19 |
2011-03-03 |
Gore Lia |
Treatment of Histone Deacetylase Mediated Disorders
|
|
US20110044952A1
(en)
*
|
2007-11-27 |
2011-02-24 |
Ottawa Health Research Institute |
Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors
|
|
EP2231596A4
(en)
*
|
2007-12-14 |
2012-06-06 |
Univ Georgetown |
INHIBITORS OF HISTONATE ACETYLASE
|
|
US7863315B2
(en)
|
2008-01-15 |
2011-01-04 |
Shenzhen Chipscreen Biosciences, Ltd. |
2-indolinone derivatives as selective histone deacetylase inhibitors
|
|
US8158656B2
(en)
|
2008-05-16 |
2012-04-17 |
Shenzhen Chipscreen Biosciences Ltd. |
2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
US8178577B2
(en)
|
2008-05-21 |
2012-05-15 |
Shenzhen Chipscreen Biosciences Ltd. |
Tricyclic derivatives as potent and selective histone deacetylase inhibitors
|
|
US8227473B2
(en)
|
2008-08-01 |
2012-07-24 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
|
|
WO2010014220A1
(en)
|
2008-08-01 |
2010-02-04 |
Lixte Biotechnology, Inc. |
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
|
|
US10354229B2
(en)
*
|
2008-08-04 |
2019-07-16 |
Mcafee, Llc |
Method and system for centralized contact management
|
|
WO2010028193A1
(en)
*
|
2008-09-03 |
2010-03-11 |
Repligen Corporation |
Compounds including pimelic acid derivatives as hdac inhibitors
|
|
GB0903480D0
(en)
|
2009-02-27 |
2009-04-08 |
Chroma Therapeutics Ltd |
Enzyme Inhibitors
|
|
US8211901B2
(en)
|
2009-05-22 |
2012-07-03 |
Shenzhen Chipscreen Biosciences Ltd. |
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
CN101906076B
(zh)
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
|
CN102020588B
(zh)
*
|
2009-09-16 |
2014-01-29 |
深圳微芯生物科技有限责任公司 |
具有组蛋白去乙酰化酶抑制活性的三环化合物、其制备方法及应用
|
|
CA2796750C
(en)
|
2010-04-20 |
2017-09-19 |
Taisho Pharmaceutical Co., Ltd. |
Novel hydroxamic acid derivative
|
|
EP2571352A4
(en)
*
|
2010-05-21 |
2014-09-17 |
Sloan Kettering Inst Cancer |
SELECTIVE HDAC HEMMER
|
|
SG10201505475XA
(en)
|
2010-07-12 |
2015-09-29 |
Celgene Corp |
Romidepsin solid forms and uses thereof
|
|
CN101894348B
(zh)
*
|
2010-07-20 |
2014-04-09 |
中兴通讯股份有限公司 |
一种自扩展的联机交易系统及其实现方法
|
|
US8859502B2
(en)
|
2010-09-13 |
2014-10-14 |
Celgene Corporation |
Therapy for MLL-rearranged leukemia
|
|
CN102775368B
(zh)
*
|
2011-05-10 |
2016-08-17 |
上海驺虞医药科技有限公司 |
一类噻唑类化合物及其制备方法和用途
|
|
US8921533B2
(en)
|
2011-07-25 |
2014-12-30 |
Chromatin Technologies |
Glycosylated valproic acid analogs and uses thereof
|
|
AU2012311640B2
(en)
*
|
2011-09-19 |
2017-04-13 |
Alfasigma S.P.A. |
New thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments
|
|
WO2013052110A1
(en)
*
|
2011-10-03 |
2013-04-11 |
The Trustees Of Columbia University In The City Of New York |
Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
|
|
US9044408B2
(en)
*
|
2011-10-31 |
2015-06-02 |
Avon Products, Inc. |
Cosmetic use of N-heteroarylbisamide analogs and related compounds
|
|
WO2013151186A1
(ja)
|
2012-04-06 |
2013-10-10 |
国立大学法人京都大学 |
エリスロポエチン産生細胞の誘導方法
|
|
AU2013202506B2
(en)
|
2012-09-07 |
2015-06-18 |
Celgene Corporation |
Resistance biomarkers for hdac inhibitors
|
|
AU2013202507B9
(en)
|
2012-11-14 |
2015-08-13 |
Celgene Corporation |
Inhibition of drug resistant cancer cells
|
|
KR20160004299A
(ko)
|
2013-04-09 |
2016-01-12 |
릭스트 바이오테크놀로지, 인코포레이티드 |
옥사바이시클로헵탄류 및 옥사바이시클로헵텐류의 제형
|
|
WO2015100363A1
(en)
|
2013-12-23 |
2015-07-02 |
The Trustees Of Columbia University In The City Of New York |
Selective hdac6 inhibitors
|
|
NZ630311A
(en)
|
2013-12-27 |
2016-03-31 |
Celgene Corp |
Romidepsin formulations and uses thereof
|
|
US11357748B2
(en)
|
2014-05-30 |
2022-06-14 |
The Johns Hopkins University |
Methods for treating mendelian disorders of the epigenetic machinery
|
|
WO2017017108A1
(en)
|
2015-07-28 |
2017-02-02 |
Vilmorin & Cie |
Method for producing haploid, dihaploid and doubled haploid plants by isolated microspore culture
|
|
TWI808055B
(zh)
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
|
|
EP4324477A3
(en)
|
2016-12-08 |
2024-05-22 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes for modulation of immune response
|
|
WO2019036607A1
(en)
*
|
2017-08-17 |
2019-02-21 |
The University Of Toledo |
IMIDAZOLE ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING THEM AND METHODS OF USE THEREOF
|
|
EP3461480A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
|
|
EP3461488A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dbait molecule and a hdac inhibitor for treating cancer
|
|
CN107698464A
(zh)
*
|
2017-10-12 |
2018-02-16 |
江苏师范大学 |
具有组蛋白去乙酰化酶抑制作用的贝利司他结构类似物及其应用
|
|
CN107822916A
(zh)
*
|
2017-11-14 |
2018-03-23 |
江苏师范大学 |
一种美白活性成分
|
|
IL312612A
(en)
|
2018-07-11 |
2024-07-01 |
Rubedo Life Sciences Inc |
Senolytic compositions and uses thereof
|
|
WO2021148581A1
(en)
|
2020-01-22 |
2021-07-29 |
Onxeo |
Novel dbait molecule and its use
|
|
EP4405680A1
(en)
|
2021-09-20 |
2024-07-31 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
|
|
EP4504165A1
(en)
|
2022-04-05 |
2025-02-12 |
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale |
Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer
|
|
WO2025026925A1
(en)
|
2023-07-28 |
2025-02-06 |
Ospedale San Raffaele S.R.L. |
Gtf2i inhibitors and uses thereof
|